From these results, we conclude that increased levels of HO-1 can prevent lipid droplet formation in the liver, ultimately preventing the development of NAFLD and NASH in obese mice. This evidence concerns the gene HMOX1 and metabolic dysfunction-associated steatotic liver disease.